Age and Ageing Advance Access published online on November 24, 2009
Age and Ageing, doi:10.1093/ageing/afp210
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study
1 Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK
2 MRC Biostatistics Unit, Cambridge CB2 0SR, UK
3 Warren Alpert Medical School of Brown University, Providence, RI 02912 USA
4 School of Population, Community and Behavioural Sciences, University of Liverpool, Liverpool L69 3GA, UK
5 Institute for Ageing and Health, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
6 Cambridge Institute for Medical Research, Addenbrookes Hospital, Cambridge CB2 2XY, UK
Address correspondence to: H.A.D. Keage; Email: hk323{at}medschl.cam.ac.uk.
Background: dementia risk conferred by apolipoprotein-E (APOE) and angiotensin-1-converting enzyme (ACE) polymorphisms have been reported for the MRC Cognitive Function and Ageing Study (CFAS) at 6-year follow-up. We concentrate on incident dementia risk over 10 years.
Methods: participants come from MRC CFAS, a multi-centre longitudinal population-based study of ageing in England and Wales. Three follow-up waves of data collection were used: 2, 6 and 10 years. Logistic regressions were undertaken to investigate associations between APOE (n = 955) and ACE (n = 856) alleles/genotypes and incident dementia. Two types of control groups were used: non-demented and highly functioning non-demented. Results were back-weighted.
Results: compared to APOE
3,
2 conferred protection of odds ratio (OR) = 0.3 (95% confidence interval, CI = 0.1–0.6) and
4 risk of OR = 2.9 (95% CI = 1.7–4.9) for incident dementia. Compared to
3/
3, the
3/
4 and
4/
4 genotypes conferred risks of OR = 3.6 (95% CI = 1.8–7.3) and OR = 7.9 (95% CI = 1.6–39.2), respectively. The
3/
2 genotype protected against dementia (OR = 0.2, 95% CI = 0.1–0.7), and
2/
2 had a similar protective effect but with wide CIs (OR = 0.3, 95% CI = 0.1–1.7). Restricting the control group accentuated these differentials. The effects of ACE alleles/genotypes on incident dementia risk were small.
Conclusions: APOE but not ACE is associated with late-onset incident dementia in the population. Using longer term follow-up with proper adjustment for attrition and incident cases increases estimates of risk.
Keywords: apolipoprotein-E, angiotensin-1-converting enzyme, population, dementia, old
Received 5 March 2009; accepted in revised form 19 October 2009.